|
243 |
Charan HV, Dwivedi DK, Khan S, Jena GB. Mechanisms
of NLRP3 inflammasome-mediated hepatic stellate cell
activation: Therapeutic potential for liver fibrosis. Genes
& Diseases 2022,
: . |
|
242 |
Gupta V, Mohapatra S, Mishra H, Farooq U, Kumar K, Ansari
MV, Aldawsari MF, Alalaiwe AS, Mirza MA, Iqbal Z. Nanotechnology
in Cosmetics and Cosmeceuticals—A Review of Latest
Advancements. Gels 2022,
8: 173. |
|
241 |
Kaundal RK, Datusalia AK, Sharma SS. Posttranscriptional
regulation of Nrf2 through miRNAs and their role in
Alzheimer's disease. Pharmacological
Research 2022,
175: 106018. |
|
240 |
Malik JA, Ahmed S, Jan B, Bender O, Al Hagbani T, Alqarni A,
Anwar S. Drugs
repurposed: An advanced step towards the treatment of breast
cancer and associated challenges. Biomedicine
and Pharmacotherapy 2022,
145: 112375. |
|
239 |
Aaghaz S, Sharma K, Jain R, Kamal A. ß-Carbolines
as potential anticancer agents. European
Journal of Medicinal Chemistry2021, 216: 113321. |
|
238 |
Aditya Gupta, Reena Sharma, Kaushik Kuche, Sanyog Jain. Exploring
the Therapeutic Potential of the Bioinspired Reconstituted
High Density Lipoprotein Nanostructures. International
Journal of Pharmaceutics 2021,
596: 120272. |
|
237 |
Bashir A, Tiwari P and Duseja A. Enzyme
replacement therapy in lysosomal acid lipase deficiency (LAL-D):
a systematic literature review. Therapeutic
Advances in Rare Disease 2021,
2: . |
|
236 |
Chakraborty S, Chormale JH and Bansal AK. Deep
eutectic systems: An overview of fundamental aspects,
current understanding and drug delivery applications. International
Journal of Pharmaceutics 2021,
610: 121203. |
|
235 |
Dar MA, Tiwari P, D'Cruz S. Assessment
of Adverse Drug Reactions due to Antimicrobial Drugs in
Medicine Inpatients at a Tertiary Care Public Teaching
Hospital. International
Journal of Medical Science in Clinical Research and Review 2021,
4: 32-40. |
|
234 |
Desale K, Kuche K, Jain S. Cell-penetrating
peptides (CPPs): an overview of applications for improving
the potential of nanotherapeutics. Biomaterials
Science 2021,
9: 1153-1188. |
|
233 |
Devi N, Madaan P, Asrar MM, Sahu JK, Bansal D. Comparative
short-term efficacy and safety of add-on anti-seizure
medications in Dravet syndrome: An indirect treatment
comparison. Seizure 2021,
91: 316-324. |
|
232 |
Kathuria D, Raul AD, Wanjari P, Bharatam PV. Biguanides:
Species with versatile therapeutic applications. European
Journal of Medicinal Chemistry 2021,
219: 113378. |
|
231 |
Kaur J, Chahal GS, Grover V, Bansal D, Jain A. Immediate
implant placement in periodontally infected sites- A
systematic review and meta-analysis. International
Academy of Periodontology 2021,
23: 115-137. |
|
230 |
Khatun S, Singh A, Bader GN, Sofi FA. Imidazopyridine,
a promising scaffold with potential medicinal applications
and structural activity relationship (SAR): recent advances. Journal
of Biomolecular Structure and Dynamics 2021,
: -. |
|
229 |
Kirar S, Thakur NS, Reddy YN, Banerjee UC, Bhaumik J, Reddy
YN. Insights
on the polypyrrole based nanoformulations for photodynamic
therapy. Journal
of Porphyrins and Phthalocyanines 2021,
25: 605-622. |
|
228 |
Luong A-D, Roy I, Malhotra BD and Luong JHT. Analytical
and biosensing platforms for insulin: A review. Sensors
and Actuators Reports 2021,
3: 100028. |
|
227 |
Malavia N, Kuche K, Ghadi R, Jain S. A
bird's eye view of the advanced approaches and strategies
for overshadowing triple negative breast cancer. Journal
of Controlled Release 2021,
330: 72-100. |
|
226 |
Mir RH, Mohi-Ud-din R, Wani TU, Dar MO, Shah AJ, Lone B,
Pooja C, Masoodi MH. Indole:
A privileged heterocyclic moiety in the management of cancer. Current
Organic Chemistry 2021,
25: 724-736. |
|
225 |
Muthusamy R, Bharatam PV. Molecular
modeling studies on cytochrome P450 mediated drug metabolism. Current
Drug Metabolism 2021,
: . |
|
224 |
Parmar PK, Rao SG and Bansal AK. Co-processing
of small molecule excipients with polymers to improve
functionality. Expert
Opinion on Drug Delivery 2021,
18: 907-992. |
|
223 |
Parmar PK, Wadhawan J, Bansal AK. Pharmaceutical
nanocrystals: A promising approach for improved topical drug
delivery. Drug
Discovery Today 2021,
: . |
|
222 |
Rashid I, Bashir A, Tiwari P, D’Cruz S, Jaswal S. Estimates
of malnutrition associated with chronic kidney disease
patients globally and its contrast with India: An evidence
based systematic review and meta-analysis. Clinical
Epidemiology and Global Health 2021,
12: 100855. |
|
221 |
Singh R, Joshi V, Mehetre N, Sangamwar AT. Insights
into co-amorphous systems in therapeutic drug delivery. Therapeutic
Delivery 2021,
12: 245-265. |
|
220 |
Sobhia ME, Kumar GS, Mallick A, Singh H, Kumar K, Chaurasiya
M, Singh M, Gera N, Deverakonda S, Baghel V. Computational
and Biological Investigations on Abl1 Tyrosine Kinase: A
Review. Current
Drug Targets 2021,
22: 38-51. |
|
219 |
Verma S, Choudhary RN, Kanadje AP, Banerjee UC. Diversifying
Arena of Drug Synthesis: In the Realm of Lipase Mediated
Waves of Biocatalysis. Catalysts 2021,
11: 1328. |
|
218 |
Bhat IA, Kabeer SW, Reza MI, Mir RH, Dar MO. AdipoRon:
A Novel Insulin Sensitizer in Various Complications and the
Underlying Mechanisms: A Review. Current
Molecular Pharmacology 2020,
13: 94-107. |
|
217 |
Chauhan G, Madou MJ, Kalra S, Chopra V, Ghosh D, Chap SOM. Nanotechnology
for COVID-19: Therapeutics and Vaccine Research. ACS
Nano 2020,
14: 7760-7782. |
|
216 |
Devi N, Boya C, Chhabra M, Bansal D. N-acetyl-cysteine
as adjuvant therapy in female infertility: A systematic
review and meta-analysis. Journal
of Basic and Clinical Physiology and Pharmacology 2020,
: . |
|
215 |
Jaladanki CK, Gahlawat A, Rathod G, Sandhu H, Jahan K,
Bharatam PV. Mechanistic
studies on the drug metabolism and toxicity originating from
cytochromes P450. Drug
Metabolism Reviews 2020,
52: 366-394. |
|
214 |
Patel D, Zode SS, Bansal AK. Formulation
aspects of intravenous nanosuspensions. International
Journal of Pharmaceutics2020, : 119555. |
|
213 |
Sharma S, Mandal A, Kant R, Jachak S, Jagzape M. Is
Cinnamon Efficacious for Glycaemic Control in Type-2
Diabetes Mellitus?.Journal
of Pakistan Medical Association 2020,
70: 2065-2069. |
|
212 |
Singh IP, Gupta S, Kumar S. Thiazole
Compounds as Antiviral Agents: An Update. Medicinal
Chemistry 2020,
16: 23-04-2022 00:00:00. |
|
211 |
Singla R, Mishra A, Joshi R, Jha S, Sharma AR, Upadhyay S,
Sarma P, Prakash A, Medhi B. Human
animal interface of SARS-CoV-2 (COVID-19) transmission: a
critical appraisal of scientific evidence. Veterinary
Research Communications 2020,
44: 119-130. |
|
210 |
Thakore SD, Sood A, Bansal AK. Emerging
Role of Primary Heterogeneous Nucleation in Pharmaceutical
Crystallization. Drug
Development Research 2020,
81: 22-03-2022 00:00:00. |
|
209 |
Thapak P, Vaidya B, Joshi HC, Singh JN, Sharma SS. Therapeutic
potential of pharmacological agents targeting TRP channels
in CNS disorders. Pharmacological
Research 2020,
159: 105026. |
|
208 |
Vaidya B, Sharma SS. Transient
Receptor Potential Channels as an Emerging Target for the
Treatment of Parkinson's Disease: An Insight Into Role of
Pharmacological Interventions. Frontiers
in Cell and Developmental Biology 2020,
8: 584513. |
|
207 |
Vishnoi S, Matre H, Garg P, Pandey SK. Artificial
intelligence and machine learning for protein toxicity
prediction using proteomics data. Chemical
Biology & Drug Design 2020,
96: 902-920. |
|
206 |
Aaghaz S, Gohel V, Kamal A. Peptides
as Potential Anticancer Agents. Current
Topics in Medicinal Chemistry 2019,
19: 1491-1511. |
|
205 |
Adhya P, Sharma SS. Redox
TRPs in diabetes and diabetic complications: mechanisms and
pharmacological modulation.Pharmacological
Research 2019,
146: 104271. |
|
204 |
Chourasiya SS, Kathuria D, Wani AA, Bharatam PV. Azines:
synthesis, structure, electronic structure and their
applications.Organic
& Biomolecular Chemistry 2019,
17: 8486-8521. |
|
203 |
Iyengar ARS, Pande AH. Is
human Paraoxonase 1 the saviour against the persistent
threat of Organophosphorus nerve agents?. Protein
& Peptide Letters 2019,
26: 471-478. |
|
202 |
Kaur H, Sharma P, Kaur S, Kaur H, Prajapat M, Mahendiratta
S, Kumar S, thota P, Prasad D, Medhi B. Therapeutic
options for management of Hori's nevus: A systematic review. Dermatologic
Therapy 2019,
33: e13167. |
|
201 |
Kesharwani SS, Kaur S, Tummala H, Sangamwar AT. Multifunctional
approaches utilizing polymeric micelles to circumvent
multidrug resistant tumors. Colloids
and Surfaces B: Biointerfaces 2019,
173: 581-590. |
|
200 |
Kuche K, Bhargavi N, Dora CP, Jain S. Drug-Phospholipid
Complex—a Go Through Strategy for Enhanced Oral
Bioavailability.AAPS
PharmSciTech 2019,
20: 43. |
|
199 |
Negi CK, Jena G. Nrf2,
a novel molecular target to reduce type 1 diabetes
associated secondary complications: The basic considerations. European
Journal of Pharmacology 2019,
843: 26-12-2022 00:00:00. |
|
198 |
Raut SY, Manne ASN, Kalthur G, Jain S, Mutalik S. Cyclodextrins
As Carriers In Targeted Delivery Of Therapeutic Agents:
Focused Review On Traditional And Inimitable Applications. Current
Pharmaceutical Design 2019,
25: 444-454. |
|
197 |
Saxena S, Chhibber M, Singh IP. Fungal
bioactive compounds in pharmaceutical research and
development. Current
Bioactive Compounds 2019,
15: 211-231. |
|
196 |
Singh K, Roy I. Nucleic
acid therapeutics in Huntington's disease. Recent
Patents on Biotechnology 2019,
13: 187-206. |
|
195 |
Sobhia ME, Ghosh K, Singh A, Sul K, Singh M, Kumar R,
Sandeep, Merugu S, Donempudi S. A
Multi-perspective Review of Dengue Research. Current
Drug Targets 2019,
20: 1550-1562. |
|
194 |
Dwivedee BP, Soni S, Sharma M, Bhaumik J, Laha JK, Banerjee
UC. Promiscuity
of Lipase-Catalyzed Reactions for Organic Synthesis: A
Recent Update. ChemistrySelect 2018,
3: 2441-2466. |
|
193 |
Gupta MN, Roy I. Rear
Mirror View of Some Biological Tools and Processes. Proceedings
of the Indian National Science Academy2018, 84:
611-624. |
|
192 |
Joshi P, Sangamwar AT. Stabilizing
supersaturated drug-delivery system through mechanism of
nucleation and crystal growth inhibition of drugs. Therapeutic
Delivery 2018,
9: 873-885. |
|
191 |
Kapoor B, Gupta R, Singh SK, Gulati M, Singh S. Prodrugs,
phospholipids and vesicular delivery - An effective
triumvirate of pharmacosomes. Advances
in Colloid and Interface Science 2018,
253: 35-65. |
|
190 |
Kaur N, Narang A, Bansal AK. Use
of biorelevant dissolution and PBPK modeling to predict oral
drug absorption. European
Journal of Pharmaceutics and Biopharmaceutics 2018,
129: 222-246. |
|
189 |
Kumar V, Patel S, Jain R. New
structural classes of antituberculosis agents. Medicinal
Research Reviews 2018,
38: 684-740. |
|
188 |
Mandal S, Bera T, Dubey G, Saha J, Laha JK. Uses
of K2S2O8 in Metal Catalyzed and Metal Free Oxidative
Transformations.ACS
Catalysis 2018,
8: 5085-5144. |
|
187 |
Prasad S, Roy I. Converting
Enzymes into Tools of Industrial Importance. Recent
Patents on Biotechnology 2018,
12: 33-56. |
|
186 |
Saini AK, Wal P, Verma M, Chandra S, Singh A, Yadav S,
Bansode H, Nischaya K, Saraswat N. Nebivolol:
An appealing, awaited and nitric oxide potentiator drug for
the treatment of heart failure. Journal
of Young Pharmacists 2018,
10: 149-154. |
|
185 |
Sharma K, Aaghaz S, Shenmar K, Jain R. Short
Antimicrobial Peptides. Recent
Patents on Anti-Infective Drug Discovery 2018,
13: 01-12-1952 00:00:00. |
|
184 |
Singh DK, Sahu A, Kumar S, Singh S. Critical
review on establishment and availability of impurity and
degradation product reference standards, challenges faced by
the users, recent developments, and trends. TrAC
Trends in Analytical Chemistry2018, 101: 85-107. |
|
183 |
Srinivasan K, Sharma SS. Endocrine
pharmacology research in India: Scientific progress in last
five years. Proceedings
of the Indian National Science Academy 2018,
84: 73-100. |
|
182 |
Jena GB, Chavan S. Implementation
of Good Laboratory Practices (GLP) in basic scientific
research: Translating the concept beyond regulatory
compliance. Regulatory
Toxicology and Pharmacology 2017,
89: 20-25. |
|
181 |
Patel KA, Sethi R, Dhara AR, Roy I. Challenges
with osmolytes as inhibitors of protein aggregation: Can
nucleic acid aptamers provide an answer?. International
Journal of Biological Macromolecules 2017,
100: 75-88. |
|
180 |
Seth K, Purohit P, Chakraborti AK. Microwave
Assisted Synthesis of Biorelevant Benzazoles. Current
Medicinal Chemistry 2017,
24: 4638-4676. |
|
179 |
Singh IP, Kumar S, Gupta S. Naphthyridines
with Antiviral Activity - A Review. Medicinal
Chemistry 2017,
13: 430-438. |
|
178 |
Iyengar AR, Pande AH. Organophosphate-Hydrolyzing
Enzymes as First-Line of Defence Against Nerve
Agent-Poisoning: Perspectives and the Road Ahead. The
Protein Journal 2016,
35: 424-439. |
|
177 |
Khan S, Ahirwar K, Jena G. Anti-fibrotic
effects of valproic acid: role of HDAC inhibition and
associated mechanisms. Epigenomics2016,
8: 1087-101. |
|
176 |
Khan S, Bhat ZR, Jena G. Role
of autophagy and histone deacetylases in diabetic
nephropathy: Current status and future perspectives. Genes
& Diseases 2016,
3: 211-219. |
|
175 |
Parikh N, Chakraborti AK. Phosphodiesterase
4 (PDE4) Inhibitors in the Treatment of COPD: Promising Drug
Candidates and Future Directions. Current
Medicinal Chemistry 2016,
23: 129-41. |
|
174 |
Patel NK, Jaiswal G, Bhutani KK. A
review on biological sources, chemistry and pharmacological
activities of pinostrobin. Natural
Product Research 2016,
30: 2017-2027. |
|
173 |
Bulani Y, Sharma SS. Therapeutic
Potential of Targeting Protease Activated Receptors in
Cardiovascular Diseases. Current
Pharmaceutical Design 2015,
21: 4392-4399. |
|
172 |
Chauhan A and Mittu B. Soil
Health - An Issue of Concern for Environment and Agriculture. Journal
of Bioremediation & Biodegradation 2015,
6: 1000286. |
|
171 |
Chauhan A, Mittu B and Chauhan P. Analytical
Method Development and Validation: A Concise Review. Journal
of Analytical & Bioanalytical Techniques 2015,
6: 1000233. |
|
170 |
Jadhavar PS, Vaja MD, Dhameliya TM, Chakraborti AK. Oxazolidinones
as Anti-tubercular Agents: Discovery, Development and Future
Perspectives. Current
Medicinal Chemistry 2015,
22: 4379-4397. |
|
169 |
Khan S, Jena G. The
role of butyrate, a histone deacetylase inhibitor in
diabetes mellitus: experimental evidence for therapeutic
intervention. Epigenomics 2015,
7: 669-80. |
|
168 |
Kharatmal SB, Singh JN, Sharma SS. Voltage-Gated
Sodium Channels as Therapeutic Targets for Treatment of
Painful Diabetic Neuropathy. Mini
Reviews in Medicinal Chemistry 2015,
15: 1134-1147. |
|
167 |
Sharma M, Akhtar N, Sambhav K, Shete G, Bansal AK, Sharma
SS. Emerging
potential of citrus flavanones as an antioxidant in diabetes
and its complications. Current
Topics in Medicinal Chemistry 2015,
15: 187-195. |
|
166 |
Dara A, Sangamwar AT. Anticancer
patent landscape and technology assessment of Indian
public-funded research institutes and organizations. Expert
Opinion on Therapeutic Patents 2014,
24: 893-912. |
|
165 |
Jain S, Rathod V, Prajapati R, Nandekar PP, Sangamwar AT. Pregnane
X Receptor and P-glycoprotein: a connexion for Alzheimer's
disease management. Molecular
Diversity 2014,
18: 895-909. |
|
164 |
Jain V, Bharatam PV. Pharmacoinformatic
approaches to understand complexation of dendrimeric
nanoparticles with drugs.Nanoscale 2014,
6: 2476-2501. |
|
163 |
Mishra S, Aeri V, Gaur PK, Jachak SM. Phytochemical,
therapeutic, and ethnopharmacological overview for a
traditionally important herb: Boerhavia diffusa Linn. BioMed
Research International 2014,
2014: Article ID 808302. |
|
162 |
Narayanam M, Handa T, Sharma P, Jhajra S, Muthe PK, Dappili
PK, Shah RP and Singh S. Critical
practical aspects in the application of liquid
chromatography-mass spectrometric studies for the
characterization of impurities and degradation products.Journal
of Pharmaceutical and Biomedical Analysis 2014,
87: 191-217. |
|
161 |
Sharma M and Garg P. Computational
Approaches for Enzyme Functional Class Prediction: A Review. Current
Proteomics 2014,
11: 17-22. |
|
160 |
Tarate B, Chavan R, Bansal AK. Oral
solid self-emulsifying formulations: a patent review. Recent
Patents on Drug Delivery & Formulation 2014,
8: 126-143. |
|
159 |
Arfeen M and Bharatam PV. Design
of Glycogen Synthase Kinase-3 Inhibitors: An Overview on
Recent Advancements. Current
Pharmaceutical Design 2013,
19: 4755-4775. |
|
158 |
Dixit VA and Bharatam PV. SAR
and Computer-Aided Drug Design Approaches in the Discovery
of Peroxisome Proliferator-Activated Receptor γ Activators:
A Perspective. Journal
of Computational Medicine 2013,
2013: Article ID 406049. |
|
157 |
Kumar A, Negi G and Sharma SS. Neuroprotection
by resveratrol in diabetic neuropathy: concepts & mechanisms. Current
Medicinal Chemistry 2013,
20: 4640-4645. |
|
156 |
Mahajan S and Singh IP. Berberine
and its derivatives: a patent review (2009 - 2012). Expert
Opinion on Therapeutic Patents2013, 23: 215-231. |
|
155 |
Mishra N, Yadav NP, Rai VK, Sinha P, Yadav KS, Jain S, Arora
S. Efficient
Hepatic Delivery of Drugs: Novel Strategies and Their
Significance. BioMed
Research International 2013,
2013: Article ID 382184. |
|
154 |
Rathod V, Jain S, Nandekar PP and Sangamwar AT. Human
pregnane X receptor: A novel target for anticancer drug
development. Drug
Discovery Today 2013,
19: 63-70. |
|
153 |
Thanki K, Gangwal R, Sangamwar AT and Jain S. Oral
delivery of anticancer drugs: Challenges and opportunities. Journal
of Controlled Release 2013,
170: 15-40. |
|
152 |
Bansal P and Ajay D. Laboratory
dialysis-past, present and future. Recent
Patents on Biotechnology 2012,
6: 32-44. |
|
151 |
Ghosh S, Chisti Y and Banerjee UC. Production
of shikimic acid. Biotechnology
Advances 2012,
30: 1425-1431. |
|
150 |
Jena G, Trivedi PP and Sandala B. Oxidative
stress in ulcerative colitis: an old concept but a new
concern. Free
Radical Research2012, 46: 1339-45. |
|
149 |
Nandekar PP and Sangamwar AT. Cytochrome
P450 1A1-mediated anticancer drug discovery: in silico
findings. Expert
Opinion on Drug Discovery 2012,
7: 771-789. |
|
148 |
Singh S, Handa T, Narayanam M, Sahu A, Junwal M and Shah RP. A
critical review on the use of modern sophisticated
hyphenated tools in the characterization of impurities and
degradation products. Journal
of Pharmaceutical and Biomedical Analysis 2012,
69: 148-173. |
|
147 |
Sobhia ME, Paul S, Shinde R, Potluri M, Gundam V, Kaur A and
Haokip T. Protein
tyrosine phosphatase inhibitors: a patent review (2002 -
2011). Expert
Opinion on Therapeutic Patents 2012,
22: 125-153. |
|
146 |
Agarwal A, Banerjee A and Banerjee UC. Xanthine
oxidoreductase: A journey from purine metabolism to
cardiovascular excitation-contraction coupling. Critical
Reviews in Biotechnology 2011,
31: 264-280. |
|
145 |
Jain AK, Das M, Swarnakar NK and Jain S. Engineered
PLGA nanoparticles: An emerging delivery tool in cancer
therapeutics.Critical
Reviews in Therapeutic Drug Carrier Systems 2011,
28: 01-01-1945 00:00:00. |
|
144 |
Jain JP, Ayen WY and Kumar N. Self
Assembling Polymers as Polymersomes for Drug Delivery. Current
Pharmaceutical Design2011, 17: 65-79. |
|
143 |
Negi G, Kumar A, Joshi RP and Sharma SS. Oxidative
stress and Nrf2 in the pathophysiology of diabetic
neuropathy: Old perspective with a new angle. Biochemical
and Biophysical Research Communications 2011,
408: 05-01-2022 00:00:00. |
|
142 |
Prajapati KD, Sharma SS and Roy N. Current
perspectives on potential role of albumin in neuroprotection. Reviews
in the Neurosciences 2011,
22: 355-363. |
|
141 |
Prasad B, Garg A, Takwani H and Singh S. Metabolite
identification by liquid chromatography-mass spectrometry. TrAC
Trends in Analytical Chemistry 2011,
30: 360-387. |
|
140 |
Singh IP and Chauthe S. Small
molecule HIV entry inhibitors - Part I: Chemokine receptor
antagonists: 2004-2010. Expert
Opinion on Therapeutic Patents 2011,
21: 227-269. |
|
139 |
Singh IP and Chauthe S. Small
molecule HIV entry inhibitors - Part II: Attachment and
fusion inhibitors: 2004-2010. Expert
Opinion on Therapeutic Patents 2011,
21: 399-416. |
|
138 |
Verma S, Domb AJ and Kumar N. Nanomaterials
for regenerative medicine. Nanomedicine 2011,
6: 157-181. |
|
137 |
Bhutani KK and Gohil VM. Natural
products drug discovery research in India: status and
appraisal. Indian
Journal of Experimental Biology 2010,
48: 199-207. |
|
136 |
Chakraborti AK, Garg SK, Kumar R, Motiwala HF and Jadhavar
PS. Progress
in COX-2 Inhibitors: A Journey So Far. Current
Medicinal Chemistry 2010,
17: 1563-1593. |
|
135 |
Kaur K, Jain M, Reddy RP and Jain R. Quinolines
and structurally related heterocycles as antimalarials. European
Journal of Medicinal Chemistry 2010,
45: 3245-3264. |
|
134 |
Singh IP and Bodiwala HS. Recent
advances in anti-HIV natural products. Natural
Product Reports 2010,
27: 1781-1800. |
|
133 |
Singh IP, Sidana J, Bharate SB and Foley WJ. Phloroglucinol
compounds of natural origin: Synthetic aspects. Natural
Product Reports 2010,
27: 393-416. |
|
132 |
Sobhia ME and Singh R. Rational
design of CCR2 antagonists: A survey of computational
studies. Expert
Opinion on Drug Discovery 2010,
5: 543-547. |
|
131 |
Vikram A, Jena GB and Ramarao P. Insulin-resistance
and benign prostatic hyperplasia: The connection. European
Journal of Pharmacology 2010,
641: 75-81. |
|
130 |
Ayenew Z, Puri V, Kumar L and Bansal AK. Trends
in pharmaceutical taste masking technologies: a patent
review. Recent
Patents on Drug Delivery & Formulation 2009,
3: 26-39. |
|
129 |
Gautam R and Jachak SM. Recent
developments in anti-inflammatory natural products. Medicinal
Research Reviews 2009,
29: 767-820. |
|
128 |
Jain NK and Roy I. Effect
of trehalose on protein structure. Protein
Science 2009,
18: 24-36. |
|
127 |
Jain S, Dani P and Sharma RK. Pharmacoscintigraphy:
a blazing trail for the evaluation of new drugs and delivery
systems.Critical
Reviews in Therapeutic Drug Carrier Systems 2009,
26: 373-426. |
|
126 |
Kaur K, Jain M, Kaur T and Jain R. Antimalarials
from nature. Bioorganic
& Medicinal Chemistry 2009,
17: 3229-3256. |
|
125 |
Khan SA, Rashmi, Hussain MZ, Prasad S and Banerjee UC. Prospects
of biodiesel production from microalgae in India.Renewable
and Sustainable Energy Reviews 2009,
13: 2361-2372. |
|
124 |
Singh IP, Sidana J, Bansal P and Foley WJ. Phloroglucinol
compounds of therapeutic interest: global patent and
technology status. Expert
Opinion on Therapeutic Patents 2009,
19: 847-866. |
|
123 |
Singh S, Prasad B, Savaliya AA, Shah RP, Gohil VM and Kaur
A. Strategies
for characterizing sildenafil, vardenafil, tadalafil and
their analogues in herbal dietary supplements, and detecting
counterfeit products containing these drugs. TrAC
Trends in Analytical Chemistry 2009,
28: 13-28. |
|
122 |
Adane L and Bharatam PV. Modelling
and informatics in the analysis of P. falciparum DHFR enzyme
inhibitors. Current
Medicinal Chemistry 2008,
15: 1552-1569. |
|
121 |
Gulati M, Singh S, Chopra D, Duggal S and Kumar R. Use
of liposomal drugs in the treatment of rheumatoid arthritis. Current
Rheumatology Reviews 2008,
4: 63-70. |
|
120 |
Hiwale P, Amin A, Kumar L and Bansal AK. Variables
affecting reconstitution time of dry powder for injection. Pharmaceutical
Technology 2008,
32: 62-68. |
|
119 |
Honrao C, Banerjee UC and Bansal P. IPR
and Technological Issues regarding a biopharmaceutical
formulation-hemoglobin.Recent
Patents on Biotechnology 2008,
2: 60-67. |
|
118 |
Jain JP, ChitkaraD, and Kumar N. Polyanhydrides
as localized drug carrier: An update. Expert
Opinion on Drug Delivery 2008,
5: 889-907. |
|
117 |
Jain JP, Sokolsky M, Kumar N and Domb AJ. Fatty
acid based biodegradable polymers. Polymer
Reviews 2008,
48: 156-191. |
|
116 |
Kaur G and Roy I. Therapeutic
applications of aptamers. Expert
Opinion on Investigational Drugs 2008,
17: 43-60. |
|
115 |
Kumar L, Amin A and Bansal AK. Salt
selection in drug development. Pharmaceutical
Technology 2008,
32: 128-146. |
|
114 |
Kumar V, Prasad B and Singh S. Pharmaceutical
issues in the development of a polypill for the treatment of
cardiovascular diseases. Drug
Discovery Today: Therapeutic Strategies 2008,
5: 63-71. |
|
113 |
Malik R and Roy I. Design
and development of antisense drugs. Expert
Opinion on Drug Discovery 2008,
3: 1189-1207. |
|
112 |
Mohan CG and Gandhi T. Therapeutic
potential of voltage gated calcium channels. Mini
Reviews in Medicinal Chemistry 2008,
8: 1285-1290. |
|
111 |
Monga V, Meena CL, Kaur N and Jain R. Chemistry
and biology of thyrotropin-releasing hormone (TRH) and its
analogs. Current
Medicinal Chemistry 2008,
15: 2718-2733. |
|
110 |
Saklani A and Kutty SK. Plant-derived
compounds in clinical trials. Drug
Discovery Today 2008,
13: 161-171. |
|
109 |
Bansal SS, Joshi A and Bansal AK. New
dosage formulations for targeted delivery of
cyclo-oxygenase-2 inhibitors: Focus on use in the elderly. Drugs
and Aging 2007,
24: 441-451. |
|
108 |
Bharatam PV, Patel DS, Adane L, Mittal A and Sundriyal S. Modeling
and informatics in the design of anti diabetic agents.Current
Pharmaceutical Design 2007,
13: 3518-3530. |
|
107 |
Bhutani KK, Birari R and Kapat K. Potential
anti-obesity and lipid lowering natural products: a review. Natural
Product Communications 2007,
2: 331-348. |
|
106 |
Birari RB and Bhutani KK. Pancreatic
lipase inhibitors from natural sources: Unexplored potential. Drug
Discovery Today 2007,
12: 879-889. |
|
105 |
Gautam R, Saklani A and Jachak SM. Indian
medicinal plants as a source of antimycobacterial agents. Journal
of Ethnopharmacology 2007,
110: 200-234. |
|
104 |
Jachak SM. PGE
synthase inhibitors as an alternative to COX-2 inhibitors. Current
Opinion in Investigational Drugs 2007,
8: 411-415. |
|
103 |
Jachak SM and Saklani A. Challenges
and opportunities in drug discovery from plants. Current
Science 2007,
92: 1251-1257. |
|
102 |
Kadam RU and Roy N. Recent
trends in drug-likeness prediction: A comprehensive review
of in silico methods. Indian
Journal of Pharmaceutical Sciences 2007,
69: 609-615. |
|
101 |
Kumar L, Amin A and Bansal AK. An
overview of automated systems relevant in pharmaceutical
salt screening. Drug
Discovery Today 2007,
12: 1046-1053. |
|
100 |
Mital A. Recent
advances in antimalarial compounds and their patents. Current
Medicinal Chemistry 2007,
14: 759-773. |
|
99 |
Mohan CG, Gandhi T, Garg D, and Shinde R. Computer
assisted methods in chemical toxicity prediction. Mini
Reviews in Medicinal Chemistry 2007,
7: 499-507. |
|
98 |
Patel DS, Dessaalew, Iqbal P and Bharatam PV. Structure-based
approaches in the design of GSK-3 selective inhibitors. Current
Protein and Peptide Science 2007,
8: 352-364. |
|
97 |
Roy I, Mondal K and Gupta MN. Leveraging
protein purification strategies in proteomics. Journal
of Chromatography. B, Analytical Technologies in the
Biomedical and Life Sciences 2007,
849: 32-42. |
|
96 |
Amin A and Bansal AK. Formulation
development for sterile liquid products in blow-fill-seal
packs. Pharmaceutical
Technology2006, 30: 142-154. |
|
95 |
Chitkara D, Shikanov A, Kumar N and Domb AJ. Biodegradable
Injectable In Situ Depot Forming Drug Delivery Systems.Macromolecular
Biosciences 2006,
6: 977-990. |
|
94 |
Italia JL, Bhardwaj V and Ravi Kumar MNV. Disease,
destination, dose and delivery aspects of ciclosporin: the
state of the art.Drug
Discovery Today 2006,
11: 846-854. |
|
93 |
Jachak SM. Cyclooxygenase
inhibitory natural products: current status. Current
Medicinal Chemistry 2006,
13: 659-678. |
|
92 |
Modi S, Prakash Jain J, Domb AJ and Kumar N. Exploiting
EPR in polymer drug conjugate delivery for tumor targeting. Current
Pharmaceutical Design 2006,
12: 4785-4796. |
|
91 |
Patel S, Kaushal AM and Bansal AK. Compression
physics in the formulation development of tablets. Critical
Reviews in Therapeutic Drug Carrier Systems 2006,
23: 01-01-1965 00:00:00. |
|
90 |
Paul AT, Gohil VM and Bhutani KK. Modulating
TNF-alpha signaling with natural products. Drug
Discovery Today 2006,
11: 725-732. |
|
89 |
Ramachandran U, Kumar R and Mittal A. Fine
tuning of PPAR ligands for type 2 diabetes and metabolic
syndrome. Mini
Reviews in Medicinal Chemistry 2006,
6: 563-573. |
|
88 |
Ratnam DV, Ankola DD, Bhardwaj V, Sahana DK and Ravi Kumar
MNV. Role
of antioxidants in prophylaxis and therapy: A pharmaceutical
perspective. Journal
of Controlled Release 2006,
113: 189-207. |
|
87 |
Shah B, Kakumanu VK and Bansal AK. Analytical
techniques for quantification of amorphous/crystalline
phases in pharmaceutical solids. Journal
of Pharmaceutical Sciences 2006,
95: 1641-1665. |
|
86 |
Sharma G, Anabousi S, Ehrhardt C and Ravi Kumar MNV. Liposomes
as targeted drug delivery systems in the treatment of breast
cancer. Journal
of Drug Targeting 2006,
14: 301-310. |
|
85 |
Singh IP and Bharate SB. Phloroglucinol
compounds of natural origin. Natural
Product Reports 2006,
23: 558-591. |
|
84 |
Singh PP. Malaria
and macrophages: Cellular and molecular basis of
pathogenesis and immune protection. Journal
of Parasitic Diseases 2006,
30: 116-124. |
|
83 |
Singh S and Kumar V. Recent
developments on long-term stability test conditions. The
Pharma Review 2006,
5: 61-68. |
|
82 |
Sundriyal S, Sharma RK and Jain R. Current
advances in antifungal targets and drug development. Current
Medicinal Chemistry2006, 13: 1321-1335. |
|
81 |
Tripathy CB and Roy N. Meta-analysis
of glutathione S-transferase M1 genotype and risk toward
head and neck cancer. Head
Neck 2006,
28: 217-224. |
|
80 |
Vangapandu S, Jain M, Kaur K, Patil P, Patel SR and Jain R. Recent
advances in antimalarial drug development. Medicinal
Research Reviews 2006,
27: 65-107. |
|
79 |
Varma MV, Perumal OP, Panchagnula R. Functional
role of P-glycoprotein in limiting peroral drug absorption:
optimizing drug delivery. Current
opinion in chemical biology 2006,
10: 367-373. |
|
78 |
Arun KHS and Ramarao P. Saga
of Renin-Angiotensin System and Calcium Channels in
Hypertensive Diabetics: Does it Have a Therapeutic Edge?. Cardiovascular
Drug Reviews 2005,
23: 99-114. |
|
77 |
Arun KHS, Kaul CL and Ramarao P. Green
fluorescent proteins in receptor research: an emerging tool
for drug discovery. Journal
of Pharmacological and Toxicological Methods 2005,
51: 23-01-2022 00:00:00. |
|
76 |
Bansal AK and Koradia V. The
role of reverse engineering in the development of generic
formulations. Pharmaceutical
Technology 2005,
29: 50-55. |
|
75 |
Gandhi R, Ashokraj Y, Kaul CL and Panchagnula R. Using
extrusion-spheronization to develop: Controlled-release
formulations of azithromycin. Pharmaceutical
Technology 2005,
29: 68-86. |
|
74 |
Jain JP, Modi S, Domb AJ and Kumar N. Role
of polyanhydrides as localized drug carriers. Journal
of Controlled Release 2005,
103: 541-563. |
|
73 |
Jain R and Chawrai S. Advancements
in the anti-diabetes chemotherapeutics based on amino acids,
peptides, and peptidomimetics. Mini
Reviews in Medicinal Chemistry 2005,
5: 469-477. |
|
72 |
Jena GB, Kaul CL and Ramarao P. Regulatory
requirements and ICH guidelines on carcinogenicity testing
of pharmaceuticals: A review on current status. Indian
Journal of Pharmacology 2005,
37: 209-222. |
|
71 |
Kashyap N, Kumar N and Ravi Kumar MNV. Hydrogels
for pharmaceutical and biomedical applications. Critical
Reviews in Therapeutic Drug Carrier Systems 2005,
22: 107-150. |
|
70 |
Kumar N, Bentolila A and Domb AJ. Structure
and biological activity of heparinoid. Mini
Reviews in Medicinal Chemistry 2005,
5: 441-447. |
|
69 |
Nayyar A and Jain R. Recent
advances in new structural classes of anti-tuberculosis
agents. Current
Medicinal Chemistry 2005,
12: 1873-1886. |
|
68 |
Rai HS, Bansal TK, Bhattacharyya MS, Banerjee UC, Singh J
and Vats P. Removal
of dyes from the effluent of textile and dyestuff
manufacturing industry: A review of emerging techniques with
reference to biological treatment. Critical
Reviews in Environmental Science and Technology 2005,
35: 219-238. |
|
67 |
Singh IP, Bharate SB and Bhutani KK. Anti-HIV
natural products. Current
Science 2005,
89: 269-290. |
|
66 |
Singh IP, Bharate SB and Bhutani KK. Interaction
of herbs and food products with drugs: Grape fruit juice as
an example.Natural
Product Radiance 2005,
4: 107-112. |
|
65 |
Singh M, Singh S, Dubey S, Soni P and Banerjee UC. Influence
of process parameters on the production of metabolites in
solid-state fermentation. Malaysian
Journal of Microbiology 2005,
1: 09-01-2022 00:00:00. |
|
64 |
Singh S, Kate BN and Banerjee UC. Bioactive
compounds from cyanobacteria and microalgae: an overview. Critical
Reviews in Biotechnology 2005,
25: 73-95. |
|
63 |
Sonkusare SK, Kaul CL and Ramarao P. Dementia
of Alzheimer's disease and other neurodegenerative
disorders—memantine, a new hope. Pharmacological
Research 2005,
51: 17-01-2022 00:00:00. |
|
62 |
Vats P, Bhattacharyya MS and Banerjee UC. Use
of phytases (myo-inositolhexakisphosphate phosphohydrolases)
for combatting environmental pollution: A biological
approach. Critical
Reviews in Environmental Science and Technology 2005,
35: 469-486. |
|
61 |
Vats RK, Kumar V, Kothari A, Mital A and Ramachandran U. Emerging
targets for diabetes. Current
Science 2005,
88: 241-249. |
|
60 |
Bala I, Hariharan S and Ravi Kumar MNV. PLGA
Nanoparticles in Drug Delivery: The State of the Art. Critical
Reviews in Therapeutic Drug Carrier Systems 2004,
21: 387-422. |
|
59 |
Banerjee A, Chisti Y and Banerjee UC. Streptokinase-a
clinically useful thrombolytic agent. Biotechnology
Advances 2004,
22: 287-307. |
|
58 |
Kalia V, Jadhav AN and Bhutani KK. Luteinizing
hormone estimation. Endocrine
Research 2004,
30: 17-01-2022 00:00:00. |
|
57 |
Kaushal AM, Gupta P and Bansal AK. Amorphous
drug delivery systems: Molecular aspects, design and
performance. Critical
Reviews in Therapeutic Drug Carrier Systems 2004,
21: 133-193. |
|
56 |
Nachaegari SK and Bansal AK. Coprocessed
excipients for solid dosage forms. Pharmaceutical
Technology (North America)2004, 28: 52-64. |
|
55 |
Panchagnula R and Agrawal S. Biopharmaceutic
and pharmacokinetic aspects of variable bioavailability of
Rifampicin.International
Journal of Pharmaceutics 2004,
271: 04-01-2022 00:00:00. |
|
54 |
Panchagnula R, Agrawal S, Ashokraj Y, Varma M, Khandavilli
S, Bhardwaj V, Bedi S, Gulati I, Parmar J, Kaul CL, Blomberg
B, Fourie B, Roscigno G, Wire R, Laing R, Evans P and Moore
T. Fixed
dose combinations for tuberculosis: Lessons learned from
clinical, formulation and regulatory perspective. Methods
and Findings in Experimental and Clinical Pharmacology 2004,
26: 703-721. |
|
53 |
Ramachandran U and Sharma M. Patent stakes of Indian
pharmaceutical industry. The
Pharma Review 2004,
2: 19-27. |
|
52 |
Ravi Kumar MNV, Hellerman G, Lockey RF and Mohapatra SS. Nanoparticle-mediated
gene delivery: the state of the art. Expert
Opinion on Biological Therapy 2004,
4: 1213-1224. |
|
51 |
Ravi Kumar MNV, Muzzarelli RA, Muzzarelli C, Sashiwa H and
Domb AJ. Chitosan
chemistry and pharmaceutical perspectives.Chemical
Reviews 2004,
104: 6017-6084. |
|
50 |
Tamilvanan S. Oil-in-water
lipid emulsions: implications for parenteral and ocular
delivering systems. Progress
in Lipid Research2004, 43: 489-533. |
|
49 |
Tamilvanan S and Benita S. The
potential of lipid emulsion for ocular delivery of
lipophilic drugs. European
Journal of Pharmaceutics and Biopharmaceutics 2004,
58: 357-368. |
|
48 |
Varma MVS, Khandavilli S, Ashokraj Y, Jain A, Dhanikula A,
Sood A, Narisetty ST, Pillai O, Sharma P, Gandhi R, Agrawal
S, Nair VB and Panchagnula R. Biopharmaceutic
classification system: A scientific framework for
pharmacokinetic optimization in drug research. Current
Drug Metabolism 2004,
5: 375-388. |
|
47 |
Vats P and Banerjee UC. Production
studies and catalytic properties of phytases (myo-inositolhexakisphosphate
phosphohydrolases): an overview. Enzyme
and Microbial Technology 2004,
35: 14-03-2022 00:00:00. |
|
46 |
Verma NK and Dey CS. RNA
Mediated gene silencing: mechanisms and its therapeutic
applications. Journal
of Clinical Pharmacy and Therapeutics 2004,
29: 395-404. |
|
45 |
Verma RK, Arora S and Garg S. Osmotic
pumps in drug delivery. Critical
Reviews in Therapeutic Drug Carrier Systems 2004,
21: 477-520. |
|
44 |
Bhutani KK. Herbal
medicines- an enigma and challenge to science and directions
for future initiatives. Indian
Journal of Natural Product 2003,
19: 10-03-2022 00:00:00. |
|
43 |
Chawla G, Gupta P, Koradia V and Bansal AK. Gastroretention
- a means to address regional variability in intestinal drug
absorption. Pharmaceutical
Technology (North America) 2003,
27: 50-68. |
|
42 |
Garg S, Raghupathi K, Vermani K, Tambwekar KR, Garg A,
Waller DP and Zaneveld LJD. Development
Pharmaceutics of Microbicide Formulations Part I:
Preformulation Considerations and Challenges. AIDS
Patient Care and STDs 2003,
17: 17-32. |
|
41 |
Garg S, Tambwekar KR, Vermani K, Raghupathi K, Garg A,
Waller DP and Zaneveld LJD. Development
Pharmaceutics of Microbicide Formulations Part II:
Formulation, Evaluation, and Challenges. AIDS
Patient Care and STDs 2003,
17: 377-399. |
|
40 |
Singal P and Singh PP. Cellular
and cytokine responses in Leishmaniasis. Journal
of Parasitic Diseases 2003,
27: 12-01-2022 00:00:00. |
|
39 |
Tambwekar KR, Madhuri V, Kakaria RB, Garg S. An
Update On Pharmacotherapies Of Smoking Cessation. Indian
Journal of Pharmaceutical Sciences 2003,
65: 450-460. |
|
38 |
Vasir JK, Tambwekar K and Garg S. Bioadhesive
microspheres as a controlled drug delivery system. International
Journal of Pharmaceutics 2003,
255: 13-32. |
|
37 |
Verma MVS, Ashokrai Y, Dey, CS and Panchagnula R. P-glycoprotein
inhibitors and their screening: a perspective from
bioavailability enhancement. Pharmacological
Research 2003,
48: 347-359. |
|
36 |
Arora P, Sharma S and Garg S. Permeability
issues in nasal drug delivery. Drug
Discovery Today 2002,
7: 967-975. |
|
35 |
Bakshi M and Singh S. Development
of validated stability-indicating assay methods—critical
review. Journal
of Pharmaceutical and Biomedical Analysis 2002,
28: 1011-1040. |
|
34 |
Banerjee A, Sharma R, Chisti Y and Banerjee UC. Botryococcus
braunii: a renewable source of hydrocarbons and other
chemicals. Critical
Reviews in Biotechnology 2002,
22: 245-279. |
|
33 |
Bansal AK. Product
development issues of powders for injection. Pharmaceutical
Technology 2002,
26: 122-132. |
|
32 |
Gupta P, Vermani K and Garg S. Hydrogels:
from controlled release to pH-responsive drug delivery. Drug
Discovery Today 2002,
7: 569-579. |
|
31 |
Jayanarayan KG and Dey CS. Microtubules:
Dynamics, drug interaction and drug resistance in Leishmania. Journal
of Clinical Pharmacy and Therapeutics 2002,
27: 313-320. |
|
30 |
Singh S, Rao KVR, Venugopal K and Manikandan R. Alteration
in dissolution characteristics of gelatin-containing
formulations: a review of the problem, test methods, and
solutions. Pharmaceutical
Technology 2002,
26: 36-58. |
|
29 |
Thiyagarajan M. α-Adrenoceptor
antagonists in the treatment of benign prostate hyperplasia. Pharmacology 2002,
65: 119-128. |
|
28 |
Verma RK, Krishna DM and Garg S. Formulation
aspects in the development of osmotically controlled oral
drug delivery systems.Journal
of Controlled Release 2002,
79: 27-07-2022 00:00:00. |
|
27 |
Vermani K and Garg S. Herbal
medicines for sexually transmitted diseases and AIDS. Journal
of Ethnopharmacology 2002,
80: 49-66. |
|
26 |
Agrawal S, Thomas NS, Dhanikula AB, Kaul CL and Panchagnula
R. Antituberculosis
drugs and new drug development. Current
Opinion in Pulmonary Medicine 2001,
7: 142-147. |
|
25 |
Garg A, Garg S, Zaneveld L and Singla A. An
update on the chemistry and pharmacology of the citrus
bioflavanoid-hesperidin.Phytotherapy
Research 2001,
15: 655-669. |
|
24 |
Kaul CL and Ramarao P. The
role of aldose reductase inhibitors in diabetic
complications: recent trends. Methods
and Findings in Experimental and Clinical Pharmacology 2001,
23: 465-475. |
|
23 |
Panchagnula R, Agrawal S and Kaul CL. Fixed
dose combinations in treatment of tuberculosis. Indian
Journal of Pharmaceutical Sciences 2001,
63: 09-01-2022 00:00:00. |
|
22 |
Pillai O and Panchagnula R. Polymers
in drug delivery. Current
Opinion in Chemical Biology 2001,
5: 447-451. |
|
21 |
Pillai O, Dhanikula AB and Panchagnula R. Drug
delivery: an odyssey of 100 years. Current
Opinion in Chemical Biology 2001,
5: 439-446. |
|
20 |
Pillai O, Nair V, Jain AK, Thomas NS and Panchagnula R. Noninvasive
transdermal delivery of peptides and proteins. Drugs
of the future 2001,
26: 779-791. |
|
19 |
Singh S, Mariappan TT, Shankar R, Sharda N and Singh B. A
critical review of the probable reasons for the poor
variable bioavailability of rifampicin from anti-tubercular
fixed-dose combination (FDC) products, and the likely
solutions to the problem.International
Journal of Pharmaceutics 2001,
228: 17-05-2022 00:00:00. |
|
18 |
Sood A and Panchagnula R. Peroral
route: an opportunity for protein and peptide drug delivery. Chemical
Reviews 2001,
101: 3275-3303. |
|
17 |
Geetha T and Singh S. Applications
of immobilized stationary-phase liquid chromatography: a
potential in vitro technique.Pharmaceutical
Science & Technology Today 2000,
3: 406-416. |
|
16 |
Grover M, Singh B, Bakshi M and Singh S. Quantitative
structure-property relationships in pharmaceutical research
- Part 1.Pharmaceutical
Science & Technology Today 2000,
3: 28-35. |
|
15 |
Grover M, Singh B, Bakshi M and Singh S. Quantitative
structure-property relationships in pharmaceutical research
- Part 2.Pharmaceutical
Science & Technology Today 2000,
3: 50-57. |
|
14 |
Jain AK and Panchagnula R. Skeletal
drug delivery systems. International
Journal of Pharmaceutics 2000,
206: 12-01-2022 00:00:00. |
|
13 |
Panchagnula R and Thomas NS. Biopharmaceutics
and pharmacokinetics in drug research. International
Journal of Pharmaceutics 2000,
201: 131-150. |
|
12 |
Panchagnula R, Jain AK, Pillai O and Jaiswal J. Nicotine
transdermal systems: pharmaceutical and clinical aspects. Methods
and Findings in Experimental and Clinical Pharmacology 2000,
22: 299-308. |
|
11 |
Panchagnula R, Pillai O, Nair VB and Ramarao P. Transdermal
Iontophoresis revisited. Current
Opinion in Chemical Biology2000, 4: 468-473. |
|
10 |
Singh S and Bakshi M. Guidance
on conduct of stress tests to determine inherent stability
of drugs. Pharmaceutical
Technology Asia 2000,
Sep: 24-36. |
|
9 |
Dhanikula AB and Panchagnula R. Localized
paclitaxel delivery. International
Journal of Pharmaceutics 1999,
183: 85-100. |
|
8 |
Nair V, Pillai O, Ramarao P and Panchagnula R. Transdermal
Iontophoresis. Part I: Basic Principles and Considerations. Methods
and Findings in Experimental and Clinical Pharmacology 1999,
21: 139-151. |
|
7 |
Pillai O, Nair V, Ramarao P and Panchagnula R. Transdermal
Iontophoresis. Part II: Peptide and Protein Delivery. Methods
and Findings in Experimental and Clinical Pharmacology 1999,
21: 229-240. |
|
6 |
Sharma P, Chawla HPS and Panchagnula R. The
role of sorption promoters in increasing the bioavailability
of drugs in oral preparations. Drugs
of the future 1999,
24: 1221-1240. |
|
5 |
Gulati M, Bajaj S, Singh S, Ferdous AJ and Singh M. Development
of liposomal amphotericin formulation. Journal
of Microencapsulation 1998,
15: 137-151. |
|
4 |
Gulati M, Grover M, Singh S and Singh M. Lipophilic
drug derivatives in liposomes. International
Journal of Pharmaceutics 1998,
165: 129-168. |
|
3 |
Panchagnula R. Pharmaceutical
aspects of paclitaxel. International
Journal of Pharmaceutics 1998,
172: 15-01-2022 00:00:00. |
|
2 |
Panchagnula R. Transdermal
delivery of drugs. Indian
Journal of Pharmacology 1997,
29: 140-156. |
|
1 |
Panchagnula R and Dey CS. Monoclonal
antibodies in drug targeting. Journal
of Clinical Pharmacy and Therapeutics 1997,
22: 19-07-2022 00:00:00. |
